Search clinical trials for: Selinexor (KPT-330)
Total 5703 results
-
Karyopharm Therapeutics IncRecruitingDiffuse Large B-cell LymphomaUnited Kingdom, United States, Australia, Austria, Belgium, Bulgaria, Canada, France, Germany, Greece, Hungary, India, Israel, Italy, Netherlands, New Zealand, Poland, Serbia, Spain
-
Gabrail Cancer Center ResearchKaryopharm Therapeutics IncCompletedCarcinoma, NeuroendocrineUnited States
-
Dana-Farber Cancer InstituteKaryopharm Therapeutics Inc; William Lawrence and Blanche Hughes FoundationActive, not recruitingRelapsed Acute Lymphoblastic Leukemia (ALL) | Refractory Acute Lymphoblastic Leukemia (ALL) | Relapsed Acute Myelogenous Leukemia (AML) | Refractory Acute Myelogenous Leukemia (AML) | Relapsed Mixed Lineage Leukemia | Refractory Mixed Lineage Leukemia | Relapsed Biphenotypic Leukemia | Refractory... and other conditionsUnited States
-
Karyopharm Therapeutics IncTerminatedCutaneous T-cell Lymphoma (CTCL) | Peripheral T-cell Lymphoma (PTCL)Australia, Singapore
-
Karyopharm Therapeutics IncTerminatedGlioma | GlioblastomaUnited States, Denmark, Netherlands
-
National University Hospital, SingaporeKaryopharm Therapeutics IncCompleted
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
Karyopharm Therapeutics IncTerminatedRichter's TransformationUnited States, Germany, United Kingdom, Spain, Poland
-
Morten Mau-SoerensenHospices Civils de Lyon; Gustave Roussy, Cancer Campus, Grand Paris; Institut... and other collaboratorsUnknownThymoma | Advanced Thymic Epithelial TumourDenmark, France
-
Karyopharm Therapeutics IncGOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaboratorsRecruitingEndometrial CancerUnited States, Belgium, Spain, Israel, Australia, Italy, Georgia, Ireland, Greece, Slovakia, Canada, Hungary, Czechia
-
University Health Network, TorontoActive, not recruitingSoft Tissue Sarcoma | Leiomyosarcoma | Endometrial Stromal Sarcoma | Malignant Peripheral Nerve Sheath Tumor (MPNST)Canada
-
Karyopharm Therapeutics IncCompletedCervical Carcinoma | Endometrial Carcinoma | Ovarian CarcinomaDenmark, Belgium
-
Karyopharm Therapeutics IncWithdrawn
-
Karyopharm Therapeutics IncRecruitingMyelofibrosisUnited States
-
Karyopharm Therapeutics IncTerminatedSquamous Cell CarcinomaUnited States, Canada
-
St. Jude Children's Research HospitalWithdrawnRhabdoid Tumor | CNS Tumor | Atypical Teratoid/Rhabdoid Tumor | Atypical Teratoid/Rhabdoid Tumor of CNSUnited States
-
Georgetown UniversityHackensack Meridian Health; Karyopharm Therapeutics IncTerminatedThymoma | Advanced Thymic Epithelial TumorUnited States
-
Karyopharm Therapeutics IncCompletedCoronavirus InfectionUnited States, Spain, France, United Kingdom, Israel, Austria
-
Karyopharm Therapeutics IncCompletedDedifferentiated LiposarcomaUnited States, United Kingdom, Israel, France, Canada, Spain, Belgium, Sweden, Germany, Italy
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Recurrent Waldenstrom... and other conditionsUnited States
-
Chongqing University Cancer HospitalRecruitingDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedChina
-
Karyopharm Therapeutics IncTerminated
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMalignant Glioma | WHO Grade 3 Glioma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Refractory Primary Central Nervous System Neoplasm | Recurrent Childhood Central Nervous System Neoplasm | Recurrent Brain Neoplasm | Recurrent Childhood...United States
-
Kari KendraKaryopharm Therapeutics IncCompletedRecurrent MelanomaUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)TerminatedPSA Progression | Metastatic Prostate Carcinoma in the Soft Tissue | Hormone-Resistant Prostate Cancer | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States
-
Erin BertinoKaryopharm Therapeutics IncTerminatedRecurrent Small Cell Lung CarcinomaUnited States
-
Karyopharm Therapeutics IncWithdrawn
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Columbia University; Karyopharm Therapeutics IncCompletedMyelodysplastic SyndromesUnited States
-
Karyopharm Therapeutics IncWithdrawnDiabetic Foot UlcersNew Zealand
-
University of ChicagoNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic SyndromeUnited States
-
Jennifer WoyachKaryopharm Therapeutics IncActive, not recruitingRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedBreast CancerUnited States
-
Mamta ParikhNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Refractory Urothelial CarcinomaUnited States
-
Erin BertinoKaryopharm Therapeutics IncWithdrawnRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma
-
Bhavana BhatnagarKaryopharm Therapeutics IncCompletedAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid LeukemiaUnited States
-
Karyopharm Therapeutics IncCompletedSarcomaUnited States, Canada
-
Asociación Europea y Latinoamericana SELNET para...RecruitingSarcoma,Soft TissueSpain
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
University of Texas Southwestern Medical CenterKaryopharm Therapeutics IncCompletedNon-small Cell Lung CancerUnited States
-
Martin GutierrezHackensack Meridian Health; Karyopharm Therapeutics IncWithdrawn
-
Matthew InghamTakeda; Karyopharm Therapeutics IncWithdrawnSarcoma | Ewing Sarcoma | Liposarcoma | Alveolar Soft Part Sarcoma | Malignant Peripheral Nerve Sheath TumorsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedGastric Cancer | Esophageal CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Karyopharm Therapeutics IncCompletedAcute Myeloid Leukemia | LeukemiaUnited States
-
Mohammed Najeeb Al HallakNational Cancer Institute (NCI)CompletedAcinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Stage IV Pancreatic CancerUnited States
-
Karyopharm Therapeutics IncCompletedSolid TumorUnited States, Denmark, Canada
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian Cancer | Endometrial CancerUnited States
-
Karyopharm Therapeutics IncActive, not recruitingLocally Advanced Unresectable or Metastatic MelanomaUnited States
-
National Cancer Institute (NCI)SuspendedGlioblastoma | Malignant Glioma | Anaplastic Astrocytoma | Anaplastic Astrocytoma, Not Otherwise Specified | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Glioblastoma, Not Otherwise SpecifiedUnited States, Canada, Australia, New Zealand
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Refractory Plasma Cell Myeloma | Recurrent Histiocytic and Dendritic Cell Neoplasm | Recurrent Non-Hodgkin Lymphoma | Refractory Histiocytic and Dendritic Cell Neoplasm | Refractory Non-Hodgkin Lymphoma | Recurrent Plasma Cell MyelomaUnited States
-
Karyopharm Therapeutics IncTerminated